Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Tyrosine Kinase JAK Inhibitors
Global Tyrosine Kinase JAK Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Tyrosine Kinase JAK Inhibitors
According to our (Global Info Research) latest study, the global Tyrosine Kinase JAK Inhibitors market size was valued at USD 31360 million in 2023 and is forecast to a readjusted size of USD 497670 million by 2030 with a CAGR of 48.4% during review period.
USD3480.00
Add To Cart
Global Tyrosine Kinase JAK Inhibitors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Tyrosine Kinase JAK Inhibitors
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Tyrosine Kinase JAK Inhibitors
Total: 2 records, 1 pages
According to our (Global Info Research) latest study, the global Tyrosine Kinase JAK Inhibitors market size was valued at USD 31360 million in 2023 and is forecast to a readjusted size of USD 497670 million by 2030 with a CAGR of 48.4% during review period.
USD3480.00
Add To Cart
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>